PERSANTIN

Main information

  • Trade name:
  • PERSANTIN 75 mg coated tablet
  • Dosage:
  • 75 mg
  • Pharmaceutical form:
  • coated tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • PERSANTIN 75 mg coated tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Dipyridamole
  • Product summary:
  • Suitability for use in older adult patients Dipyridamolum Avoid using in older persons. Take into account adverse effects, such as symptoms of angina pectoris and dizziness. The efficacy of the drug alone (without acetylsalicylic acid) is modest.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 4953
  • Authorization date:
  • 15-05-2006
  • Last update:
  • 21-02-2018